Crowdonomics
All companies
Neureka® for Epilepsy logo

Neureka® for Epilepsy

Operating

Novela Neurotechnologies, Inc.

Healthcare · Alameda, CA · Founded 2018

Woman-foundedImmigrant-founded
Visit website

Epilepsy care reimagines: AI-powered wearables for on-demand care, 24/7

Valuation cap ⓘ
$25.0M
As of Apr 2023 · from Neureka for Epilepsy Crowd SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$87,101
Across 1 round since 2023

Financials

FY2020–FY2023 · from SEC filings · hover any figure for its source
$0
−$962K
2020
$0
−$1.4M
2021
$225K
−$986K
2022
−$140K
−$1.2M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$0
$0
$225,244
-$139,685
Cost of goods sold
$0
$0
$38,511
$42,435
Gross margin
—
—
83%
—
Net income
-$962,316
-$1,393,497
-$986,188
-$1,192,435
Taxes paid
$0
$0
$1,904
$3,205
Balance sheet
Cash
$64,459
$281,299
$60,200
$99,207
Accounts receivable
$0
$0
$217,700
$0
Total assets
$71,179
$286,340
$2,628,933
$2,289,146
Short-term debt
$34,704
$50,065
$23,156
$12,579
Long-term debt
$42,167
$20,171
$2,069,466
$2,019,466
Total liabilities
$76,871
$70,236
$2,092,622
$2,032,045
Other
Headcount
—
2
—
2

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Post-money = pre-money + amount raised · caps marked
$25.0M
Valuation cap
Neureka for Epilepsy Crowd SAFE 1

A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.

Fundraising history

Neureka for Epilepsy Crowd SAFE 1ClosedReg CF · SAFE · via Republic
Raised $87.1K / $1.2MInvestors 100Valuation cap $25M

Team

2 people
Rawy Iskander
Chief Executive Officer
Kevin Charles Hildreth
Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 1 of 4 annual reports (FY2022–FY2025)

100 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARApr 23, 20240001768586-24-000003
    EDGAR
  • Form C-UApr 21, 20230001768586-23-000002
    EDGAR
  • Form CFeb 14, 20230001768586-23-000001
    EDGAR
  • Form DFeb 21, 20190001768586-19-000001
    EDGAR
Source: ManualCIK 0001768586CA

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.